Loading...

AUTOIMMUNE EPILEPSY

image not found

 NABL Cap Accredited 
The Autoimmune Epilepsy Profile at Metropolis Healthcare is a specialized diagnostic panel designed to detect autoantibodies associated with immune-mediated seizures. This profile helps identify autoimmune causes of epilepsy, especially in patients with new-onset, drug-resistant, or rapidly progressing seizures. By using advanced immunological assays, Metropolis Healthcare ensures accurate detection of neuronal and systemic antibodies linked to autoimmune encephalitis. Early identification of an autoimmune trigger allows timely treatment, often improving seizure control and neurological outcomes

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 39,000.00

Sample Type: Serum

Fasting Not Required


Notes:N8292

Frequently Asked Questions (FAQ's):

 What does the Autoimmune Epilepsy Profile include?

It screens for specific neuronal and systemic autoantibodies associated with autoimmune encephalitis and immune-mediated seizure disorders.

Why is this test important?
It helps detect treatable autoimmune causes of epilepsy, enabling early intervention and better long-term seizure management.

Who should take this test?
Individuals with unexplained seizures, rapid symptom progression, poor response to anti-seizure medications, or suspected autoimmune encephalitis may require this profile.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassay platforms and antibody panels to ensure high sensitivity and specificity.

What type of sample is required?
A serum sample is typically required; in some cases, your doctor may also request CSF testing.

Is any special preparation needed?
No fasting or preparation is required before sample collection.

How soon are the results available?
Metropolis Healthcare usually provides timely results to support urgent neurological treatment planning.

Can this test guide treatment decisions?
Yes, identifying autoimmune antibodies helps clinicians initiate immunotherapy or targeted treatments for better seizure control

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab